Joey A. Jacobs Sells 500,000 Shares of Acadia Healthcare Company, Inc. (ACHC) Stock
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) CEO Joey A. Jacobs sold 500,000 shares of the firm’s stock in a transaction on Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total value of $25,345,000.00. Following the completion of the sale, the chief executive officer now owns 201,496 shares in the company, valued at $10,213,832.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
Acadia Healthcare Company, Inc. (NASDAQ ACHC) opened at 47.43 on Thursday. The company’s 50 day moving average price is $50.34 and its 200-day moving average price is $45.31. Acadia Healthcare Company, Inc. has a 12-month low of $32.54 and a 12-month high of $54.34. The stock has a market cap of $4.17 billion, a price-to-earnings ratio of 521.21 and a beta of 1.15.
Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Thursday, July 27th. The company reported $0.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.65 by $0.01. Acadia Healthcare had a net margin of 0.30% and a return on equity of 8.69%. The firm had revenue of $715.90 million during the quarter, compared to the consensus estimate of $717.38 million. During the same period last year, the firm posted $0.73 EPS. The firm’s quarterly revenue was down 5.4% on a year-over-year basis. On average, analysts forecast that Acadia Healthcare Company, Inc. will post $2.45 EPS for the current year.
TRADEMARK VIOLATION WARNING: This report was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this report can be viewed at https://www.thecerbatgem.com/2017/08/24/joey-a-jacobs-sells-500000-shares-of-acadia-healthcare-company-inc-achc-stock.html.
A number of institutional investors have recently made changes to their positions in the stock. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Acadia Healthcare by 11.1% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,704 shares of the company’s stock valued at $134,000 after buying an additional 270 shares in the last quarter. C M Bidwell & Associates Ltd. purchased a new position in shares of Acadia Healthcare during the second quarter valued at about $205,000. Riverhead Capital Management LLC purchased a new position in shares of Acadia Healthcare during the second quarter valued at about $209,000. Emerald Mutual Fund Advisers Trust purchased a new position in shares of Acadia Healthcare during the first quarter valued at about $210,000. Finally, Paloma Partners Management Co purchased a new position in shares of Acadia Healthcare during the first quarter valued at about $217,000.
ACHC has been the topic of a number of analyst reports. Cantor Fitzgerald restated a “hold” rating and issued a $45.00 price target on shares of Acadia Healthcare in a research note on Wednesday, April 26th. Zacks Investment Research upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Friday, April 28th. Jefferies Group LLC restated a “buy” rating on shares of Acadia Healthcare in a research note on Friday, May 5th. Leerink Swann cut Acadia Healthcare from an “outperform” rating to a “market perform” rating in a research note on Monday, May 15th. Finally, KeyCorp restated an “overweight” rating and issued a $51.00 price target on shares of Acadia Healthcare in a research note on Thursday, June 1st. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. The stock has an average rating of “Buy” and an average target price of $59.21.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Stock Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related stocks with our FREE daily email newsletter.